findmyKOL
Clinical trialNCT00086957CompletedPhase 1/PHASE2Interventional

Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer

SponsorCity of Hope Medical CenterEnrollment31Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Tower Cancer Research Foundation

    Beverly Hills, California, United States

  • City of Hope Comprehensive Cancer Center

    Duarte, California, United States

  • Hematology Oncology Consultants-Hemet

    Hemet, California, United States

  • Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center

    Long Beach, California, United States

  • Usc/norris Comprehensive Cancer Center and Hospital

    Los Angeles, California, United States

  • City of Hope Medical Group

    Pasadena, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2004
Primary completion
31 Aug 2015
Completion
31 Aug 2015
Last update posted
27 Feb 2017
Registered enrollment
31
Registry id
NCT00086957

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.